Related references
Note: Only part of the references are listed.Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth
Dong Joon Kim et al.
CANCER RESEARCH (2012)
Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma
Di-Cing Wei et al.
CANCER SCIENCE (2012)
Analysis of EGFR, KRAS and P53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy
Fumihiro Yamaguchi et al.
LUNG CANCER (2012)
TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer
M-C Shih et al.
ONCOGENE (2012)
CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma
Brian S. Erler et al.
TUMOR BIOLOGY (2011)
Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore
Hui Wan Chua et al.
BMC CANCER (2010)
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
I. Zlobec et al.
BRITISH JOURNAL OF CANCER (2010)
T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of Prx1 at Ser-32 Prevents UVB-induced Apoptosis in RPMI7951 Melanoma Cells through the Regulation of Prx1 Peroxidase Activity
Tatyana A. Zykova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
F. Hu et al.
ONCOGENE (2010)
Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer
Tomasz Targowski et al.
RESPIRATORY MEDICINE (2010)
Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target
D. Herrero-Martin et al.
BRITISH JOURNAL OF CANCER (2009)
The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer
Chang Hyun Kang et al.
ANNALS OF THORACIC SURGERY (2008)
A mitotic kinase TOPK enhances cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis
Yasuhito Abe et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT1 16 colorectal cancer cells
Feng Zhu et al.
GASTROENTEROLOGY (2007)
Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein-protein interaction with tumor suppressor p53
Asit K. Nandi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
TOPK promotes tumour cell proliferation through p38MAPK activity and regulation of the DNA damage response
V. Ayllon et al.
ONCOGENE (2007)
Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer
Hiroyoshi Tsubochi et al.
ANNALS OF THORACIC SURGERY (2006)
PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer
Jae-Hyun Park et al.
CANCER RESEARCH (2006)
Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer - Immunocytochemical detection with imprint cytology
C Maddau et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer
KH Paik et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2006)
PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase
JD Dougherty et al.
JOURNAL OF NEUROSCIENCE (2005)
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke:: Distinct patterns in never, former, and current smokers
F Le Calvez et al.
CANCER RESEARCH (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells
A Nandi et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53
C Mascaux et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells
M Simons-Evelyn et al.
BLOOD CELLS MOLECULES AND DISEASES (2001)
PDZ-binding kinase participates in spermatogenesis
SH Zhao et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Expression of cyclin D1, Ki-67 and PCNA in nonsmall cell lung cancer:: prognostic significance and comparison with p53 and bcl-2
VN Nguyen et al.
ACTA HISTOCHEMICA (2000)
Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells
Y Abe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Characterization of PDZ-binding kinase, a mitotic kinase
S Gaudet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
